The Pot Report. Get the Report
The week in cannabis, in five minutes.Free, every week, from The Pot Report.
Get the Report

Washington

Medical · California, Colorado, Washington · 23 minutes ago

From Medical Marijuana to Marijuana Everywhere | Psychology Today

A Psychology Today commentary argues that commercial marijuana legalization has drifted far from its medical roots. It says today's high-potency products raise psychosis and cannabis use disorder risks, and that heavy users drive sales. It also cites an estimated $29.1 billion in 2025 US legal sales and compares the cannabis industry's marketing and lobbying to Big Tobacco's. Marijuana legalization is the focus.

Why it matters: The commentary reflects a growing public health argument that legal cannabis is a commercial product, not a medicine. For consumers and patients, it highlights the gap between dispensary products and tested medicines, and the potency trend. It also signals continued pressure for tighter marketing, potency and warning rules, though it is an opinion piece rather than a policy change.

Read moreSource: psychologytoday.com

Laws · Colorado, Massachusetts, Washington · November 17, 2026

NORML Op-Ed: As More States Regulate Cannabis, Teen Use Has Never Been Lower

NORML, the marijuana legalization advocacy group, argues in a commentary that teen cannabis use has hit its lowest level in 30 years as states regulate adult markets. It cites CDC data, drops in teen use in Colorado, Washington, Massachusetts and Ohio, and dispensary ID checks, and says legal states have not repealed their laws.

Why it matters: The teen-use argument is central to the fight over legal markets, and Massachusetts voters just weighed it at the ballot box. This is an advocacy group's case, not independent research. For adult buyers, it signals that supporters will keep pointing to strict ID checks and licensed sales as the reason legal retail should stay.

Read moreSource: norml.org

Laws · Illinois, Massachusetts, Washington · November 15, 2026

The Operator Bulletin: Hemp Limits, Testing Rules, Grower Co-ops – mg Magazine

Illinois hemp rules are now in force: since November 12, consumable and topical products with more than 0.4mg of total THC per container count as cannabis and can only be sold at licensed dispensaries. Massachusetts advanced testing and labeling proposals, Washington floated grower co-ops, and California clarified plant transfer rules.

Why it matters: Hemp shoppers in Illinois will find high-THC products pulled from non-dispensary shelves, and the same federal cap is set for December 11 nationwide. Massachusetts buyers could eventually see labels disclosing sanitizing or remediation, and automatic retesting of failed batches. Co-op and transfer changes mostly affect growers, though they may shape costs and supply.

Read moreSource: mgmagazine.com